Literature DB >> 15860250

Nuclear hormone receptor co-repressors.

Aria Baniahmad1.   

Abstract

Gene silencing is an essential transcriptional regulatory process. Co-repressors mediate gene repression through their recruitment by DNA bound transcriptional silencer proteins. Co-repressors repress gene expression through several mechanisms, mostly investigated on the level of chromatin. Lack or aberrant gene silencing is associated with many defects both on cellular and organismic level. Several human diseases are based on dysregulated co-repressor binding to transcriptional silencers indicating that co-repressor recruitment and the strength of gene silencing must be under strict control. In line with that gene silencing is important for animal development, cellular proliferation and transformation. Co-repressors play also a major role in the treatment of hormone-dependent growing cancers, such as for breast and prostate cancer therapy. The molecular basis of anti-hormone therapy lies in the recruitment of co-repressors to the estrogen or androgen receptors, respectively, which leads to their inactivation and to inhibition of cancer growth. The molecular mechanisms of selected topics are summarized here.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15860250     DOI: 10.1016/j.jsbmb.2004.12.012

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  12 in total

1.  Interrelation of androgen receptor and miR-30a and miR-30a function in ER-, PR-, AR+ MDA-MB-453 breast cancer cells.

Authors:  Shuhua Lyu; Han Liu; Xia Liu; Shan Liu; Yahong Wang; Qi Yu; Yun Niu
Journal:  Oncol Lett       Date:  2017-08-21       Impact factor: 2.967

2.  A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression.

Authors:  Wei Qi; Hong Wu; Lin Yang; Douglas D Boyd; Zhengxin Wang
Journal:  EMBO J       Date:  2006-12-14       Impact factor: 11.598

3.  HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment.

Authors:  Khairul I Ansari; Imran Hussain; Bishakha Shrestha; Sahba Kasiri; Subhrangsu S Mandal
Journal:  J Mol Biol       Date:  2011-06-12       Impact factor: 5.469

4.  A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.

Authors:  Mohsen Esmaeili; Thanakorn Pungsrinont; Andrea Schaefer; Aria Baniahmad
Journal:  J Mol Med (Berl)       Date:  2016-06-16       Impact factor: 4.599

Review 5.  LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer.

Authors:  Arunoday Bhan; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-07-21

6.  Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth.

Authors:  M Marzioni; P Invernizzi; C Candelaresi; M Maggioni; S Saccomanno; C Selmi; C Rychlicki; L Agostinelli; B Cassani; M Miozzo; S Pasini; G Fava; G Alpini; A Benedetti
Journal:  Dig Liver Dis       Date:  2008-10-22       Impact factor: 4.088

7.  Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing.

Authors:  Brian A Jonas; Natalia Varlakhanova; Fumihiko Hayakawa; Michael Goodson; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2007-05-22

8.  The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists.

Authors:  Tamotsu Tsukahara
Journal:  PPAR Res       Date:  2012-05-29       Impact factor: 4.964

9.  Distinct DNA binding sites contribute to the TCF transcriptional switch in C. elegans and Drosophila.

Authors:  Chandan Bhambhani; Aditi J Ravindranath; Remco A Mentink; Mikyung V Chang; Marco C Betist; Yaxuan X Yang; Sandhya P Koushika; Hendrik C Korswagen; Ken M Cadigan
Journal:  PLoS Genet       Date:  2014-02-06       Impact factor: 5.917

10.  Pterostilbene-isothiocyanate conjugate suppresses growth of prostate cancer cells irrespective of androgen receptor status.

Authors:  Kumar Nikhil; Shruti Sharan; Ajanta Chakraborty; Partha Roy
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.